NHLBI Clinical Ancillary Studies (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) seeks to accelerate the pace and expand the breadth of scientific research on the clinical course, prevention and treatment of diseases within NHLBI's mission by leveraging ongoing clinical research studies through ancillary studies. This FOA invites research project applications to conduct ancillary studies to clinical research studies, including clinical trials,  prospective observational studies, and/or registries. Applications submitted to this FOA should propose to collect new information and/or biological samples from participants of the ongoing parent study, and should address new research questions that are beyond those specified in the approved protocol of the parent study and are within the scientific mission of the NHLBI. Applications submitted to this FOA should not be used to extend the duration of the parent study or to provide funds solely for parent study enrollment, capitation, or study performance.

Deadlines:

  • Letter of Intent: 30 days prior to the application due date
  • Application Due Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020
  • AIDS Application Due Date(s):¬†April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020

PAR-18-643 Expiration Date December 19, 2020

Agency Website

Amount

$1,000,000

Amount Description

Application budgets may not exceed $250,000 in direct costs per year.

The scope of the proposed project should determine the project period. The maximum project period is four years.

      Funding Type

      Grant

      Eligibility

      Faculty

      Category

      Environmental & Life Sciences
      Medical
      Medical - Clinical Science

      External Deadline

      April 30, 2020